Daniel Appelbaum to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Daniel Appelbaum has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.047
-
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 06 17; 137(24):3454-3459.
Score: 0.047
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.